204 related articles for article (PubMed ID: 34172079)
21. Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Manifestation: A Case Report.
Razzeto A; Garala P; Amoozgar B; Daliparty VM; Rehman F; Razzeto M
Am J Case Rep; 2021 Sep; 22():e932887. PubMed ID: 34550964
[TBL] [Abstract][Full Text] [Related]
22. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
23. Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm.
Agha ME; Monaghan SA; Swerdlow SH
N Engl J Med; 2018 Oct; 379(15):1479-1481. PubMed ID: 30304659
[No Abstract] [Full Text] [Related]
24. Venetoclax to treat relapsed blastic plasmacytoid dendritic cell neoplasm: A case-report and review of literature.
Beziat G; Ysebaert L; Gaudin C; Steinmeyer Z; Balardy L
Leuk Res; 2019 Oct; 85():106199. PubMed ID: 31415942
[No Abstract] [Full Text] [Related]
25. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
[TBL] [Abstract][Full Text] [Related]
26. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.
Wang H; Cao J; Hong X
Acta Haematol; 2012; 127(2):124-7. PubMed ID: 22236870
[TBL] [Abstract][Full Text] [Related]
27. A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.
Kaur V; Swami A; Shebli A; Shalin S; Veeraputhiran M; Emanuel P; Jethava Y
J Oncol Pharm Pract; 2017 Oct; 23(7):552-556. PubMed ID: 27559020
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm].
Saika W; Kawahara M; Tashiro H; Teramoto Y; Nagai S; Kumode M; Iwasa M; Asai A; Fujishiro A; Nishimura R; Minamiguchi H; Moritani S; Kito K; Andoh A
Rinsho Ketsueki; 2020; 61(12):1647-1653. PubMed ID: 33441515
[TBL] [Abstract][Full Text] [Related]
29. Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm.
Nagate Y; Nakaya A; Kamimura R; Hirose Y; Nojima S; Fujita J; Kiyohara E; Shibayama H
Intern Med; 2023; 62(17):2547-2551. PubMed ID: 37661416
[TBL] [Abstract][Full Text] [Related]
30. Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.
Le Calloch R; Arnaud B; Le Clech L; Hutin P; Salmon F; Garnache Ottou F; Ianotto JC; Laribi K
Ann Hematol; 2022 Jun; 101(6):1347-1349. PubMed ID: 35249131
[No Abstract] [Full Text] [Related]
31. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
32. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer S; Eichhorst B; Schetelig J; Coutre S; Seymour JF; Munir T; Puvvada SD; Wendtner CM; Roberts AW; Jurczak W; Mulligan SP; Böttcher S; Mobasher M; Zhu M; Desai M; Chyla B; Verdugo M; Enschede SH; Cerri E; Humerickhouse R; Gordon G; Hallek M; Wierda WG
Lancet Oncol; 2016 Jun; 17(6):768-778. PubMed ID: 27178240
[TBL] [Abstract][Full Text] [Related]
33. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy.
Narli Ozdemir Z; Cengiz Seval G; Sahin U; Uslu A; Gunduz M; Civriz Bozdag S; Toprak SK; Kurt Yuksel M; Topcuoglu P; Kuzu I; Ozcan M; Gurman G; Ilhan O
Indian J Hematol Blood Transfus; 2021 Jan; 37(1):67-75. PubMed ID: 33707837
[TBL] [Abstract][Full Text] [Related]
34. Blastic Plasmacytoid Dendritic Cell Neoplasm: Case Report and Literature Overview.
Kolerova A; Sergeeva I; Krinitsyna J; Pronkina N; Sizikova S; Filimonov P; Kryuchkova I
Indian J Dermatol; 2020; 65(3):217-221. PubMed ID: 32565565
[TBL] [Abstract][Full Text] [Related]
35. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
Pagano L; Valentini CG; Grammatico S; Pulsoni A
Br J Haematol; 2016 Jul; 174(2):188-202. PubMed ID: 27264021
[TBL] [Abstract][Full Text] [Related]
36. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
[TBL] [Abstract][Full Text] [Related]
37. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
Seymour JF; Ma S; Brander DM; Choi MY; Barrientos J; Davids MS; Anderson MA; Beaven AW; Rosen ST; Tam CS; Prine B; Agarwal SK; Munasinghe W; Zhu M; Lash LL; Desai M; Cerri E; Verdugo M; Kim SY; Humerickhouse RA; Gordon GB; Kipps TJ; Roberts AW
Lancet Oncol; 2017 Feb; 18(2):230-240. PubMed ID: 28089635
[TBL] [Abstract][Full Text] [Related]
38. Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: A case report.
Gao NA; Wang XX; Sun JR; Yu WZ; Guo NJ
Exp Ther Med; 2015 Apr; 9(4):1109-1112. PubMed ID: 25780395
[TBL] [Abstract][Full Text] [Related]
39. Blastic plasmacytoid dendritic cell neoplasm: report of a case presenting with lung and central nervous system involvement and review of the literature.
Feng Z; Zhou J; Bentley G
J La State Med Soc; 2014; 166(1):2-9. PubMed ID: 25075501
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
Sakashita K; Saito S; Yanagisawa R; Tanaka M; Yoshikawa K; Hirabayashi K; Tsukahara K; Motobayashi M; Nakazawa Y; Koike K
Pediatr Blood Cancer; 2013 Nov; 60(11):E140-2. PubMed ID: 23788509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
